| Stage | VFC | % of rev | CHTR | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $2.7B | 100.00% | $13.5B | 100.00% | CHTR ×5.02 |
| Gross profit | $1.5B | 55.38% | $13.5B | 100.00% | CHTR +44.6pp |
| Operating income | $368M | 13.65% | $3.1B | 22.65% | CHTR +9.0pp |
| Pre-tax income | $347M | 12.87% | $2.0B | 14.78% | CHTR +1.9pp |
| Net income | $285M | 10.58% | $1.5B | 11.27% | CHTR +0.7pp |
| Stage | VFC | CHTR | Gap · A − B |
|---|---|---|---|
| Revenue | $2.7B100.00% | $13.5B100.00% | CHTR ×5.02 |
| Gross profit | 55.38%$1.5B | 100.00%$13.5B | CHTR +44.6pp |
| Operating income | 13.65%$368M | 22.65%$3.1B | CHTR +9.0pp |
| Pre-tax income | 12.87%$347M | 14.78%$2.0B | CHTR +1.9pp |
| Net income |
| 10.58%$285M |
| 11.27%$1.5B |
| CHTR +0.7pp |
No shared counterparties.